Breadcrumb Home News & Events News & Events News April 2022 Announcements The International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network is delighted to announce the publication of results from IMPAACT P1093 in the May 2022 edition of The Lancet HIV. March 2022 Announcements IMPAACT 2017 (MOCHA) Data Informs U.S. FDA Approval of Cabenuva for HIV Treatment in Virologically Suppressed Adolescents March 2022 Announcements IMPAACT 2014 Informs U.S. FDA’s Approval for Use of Doravirine in Pifeltro® and Delstrigo® Among Children Search Enter a search term. Filter Topics AllAnnouncementsMeetingsStudy Results Date All2022202120202019201820162014 Sort Date AscDate Desc Submit Search Showing 21 news items. April 2022 Announcements The International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network is delighted to announce the publication of results from IMPAACT P1093 in the May 2022 edition of The Lancet HIV. March 2022 Announcements IMPAACT 2017 (MOCHA) Data Informs U.S. FDA Approval of Cabenuva for HIV Treatment in Virologically Suppressed Adolescents March 2022 Announcements IMPAACT 2014 Informs U.S. FDA’s Approval for Use of Doravirine in Pifeltro® and Delstrigo® Among Children November 2021 Announcements IMPAACT Investigator Identifies COVID-19 Omicron Variant November 2021 Announcements IMPAACT Remembers Carol Onyango September 2021 Announcements IMPAACT P1108 Informs WHO TB Management Recommendation May 2021 Announcements IMPAACT MOP Updated April 2021 Announcements HANC Webinar Announcement March 2021 Announcements Recent Updates to DAIDS Policies, Procedures, and Guidance Documents March 2021 Announcements European Commission Grants EMA Approval for Dolutegravir Dispersible Tablets For the Treatment of Children Living with HIV in Europe Pagination Current page 1 Page 2 Page 3 Next page Next
April 2022 Announcements The International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network is delighted to announce the publication of results from IMPAACT P1093 in the May 2022 edition of The Lancet HIV.
March 2022 Announcements IMPAACT 2017 (MOCHA) Data Informs U.S. FDA Approval of Cabenuva for HIV Treatment in Virologically Suppressed Adolescents
March 2022 Announcements IMPAACT 2014 Informs U.S. FDA’s Approval for Use of Doravirine in Pifeltro® and Delstrigo® Among Children
April 2022 Announcements The International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network is delighted to announce the publication of results from IMPAACT P1093 in the May 2022 edition of The Lancet HIV.
March 2022 Announcements IMPAACT 2017 (MOCHA) Data Informs U.S. FDA Approval of Cabenuva for HIV Treatment in Virologically Suppressed Adolescents
March 2022 Announcements IMPAACT 2014 Informs U.S. FDA’s Approval for Use of Doravirine in Pifeltro® and Delstrigo® Among Children
March 2021 Announcements European Commission Grants EMA Approval for Dolutegravir Dispersible Tablets For the Treatment of Children Living with HIV in Europe
